Table Of Contents:

1. Market Context & Strategic Relevance

 1.1 Opening Context (Why the market matters)

 1.1.1 Why This Market Is Gaining Strategic Attention

     1.1.2 Business Decisions This Report Supports

 1.2 Scope

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size by Product

  2.3.2 Market Size by Technology

  2.3.3 Market Size by Application

 2.3.4 Market Size by End User

 2.4 Market Share & Bps Analysis by Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

3.4.1 Raw Material & Reagent Suppliers

3.4.2 INAAT Kit & Instrument Manufacturers

3.4.3 Distributors & Diagnostic Solution Providers

3.4.4 End Users / Clinical & Research Laboratories

 3.5 Industry Life Cycle Assessment

4. Statistical Insights & Trends Reporting

4.1 Molecular Diagnostics & Infectious Disease Testing Trends (2025)

4.1.1 Global Molecular Diagnostic Test Volume Trends

4.1.2 Infectious Disease Testing Demand by Indication

4.1.3 Point-of-Care Molecular Testing Adoption Trends

4.1.4 Decentralized Diagnostic Testing Expansion

4.2 Isothermal Amplification Technology Adoption Trends (2025)

4.2.1 Technology Adoption by Amplification Method (LAMP, RPA, HDA, NASBA, SDA)

4.2.2 Laboratory vs. Point-of-Care INAAT Utilization Trends

4.2.3 Clinical, Veterinary & Food Testing Application Analysis

4.2.4 Cartridge-Based and Portable Molecular Platform Adoption

4.3 Diagnostic R&D & Investment Trends (2025)

4.3.1 Molecular Diagnostics R&D Investment by Region

4.3.2 Infectious Disease Diagnostic Development Activity

4.3.3 Public Health & Pandemic Preparedness Funding Trends

4.3.4 Companion Diagnostic and Precision Medicine Research Trends

4.4 Regulatory & Commercialization Trends (2025)

4.4.1 Regulatory Approvals for Molecular Diagnostic Assays

4.4.2 Emergency Use Authorization (EUA) and IVD Approval Trends

4.4.3 Reimbursement and Market Access Developments

4.4.4 Decentralized Testing Regulatory Framework Trends

4.5 Technology & Innovation Trends (2025)

4.5.1 CRISPR-Based Isothermal Diagnostic Development Trends

4.5.2 Multiplex Isothermal Assay Adoption Trends

4.5.3 Microfluidics and Lab-on-a-Chip Integration Trends

4.5.4 AI-Enabled Molecular Diagnostics and Digital Connectivity Trends

5. Isothermal Nucleic Acid Amplification Technology Market Segmental Analysis & Forecast, By Product, 2022–2035, Value (USD Billion)

5.1 Introduction

 5.2 Assay

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022–2035

 5.3 Kits and Reagents

 5.4 Systems

6. Isothermal Nucleic Acid Amplification Technology Market Segmental Analysis & Forecast, By Technology, 2022–2035, Value (USD Billion)

    6.1 Introduction

 6.2 Loop-Mediated Isothermal Amplification (LAMP)

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022–2035

6.3 Nucleic Acid Sequence-Based Amplification (NASBA)

6.4 Transcription-Mediated Amplification (TMA)

6.5 Strand Displacement Amplification (SDA)

6.6 Nicking Enzyme Amplification Reaction (NEAR)

6.7 Recombinase Polymerase Amplification (RPA)

6.8 Helicase-Dependent Amplification (HDA)

6.9 Single Primer Isothermal Amplification (SPIA)

6.10 Others

7. Isothermal Nucleic Acid Amplification Technology Market Segmental Analysis & Forecast, By Application, 2022–2035, Value (USD Billion)

    7.1 Introduction

 7.2 Infectious Disease Diagnostics

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022–2035

7.3 Blood Screening

7.4 Oncology

7.5 Laboratory Research

7.6 Others

8. Isothermal Nucleic Acid Amplification Technology Market Segmental Analysis & Forecast, By End User, 2022–2035, Value (USD Billion)

    8.1 Introduction

 8.2 Hospitals

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022–2035

8.3 Central and Reference Laboratories

8.4 Academic and Research Institutions

8.5 Others

9. Isothermal Nucleic Acid Amplification Technology Market Segmental Analysis & Forecast by Region, 2022–2035, Value (USD Billion)

9.1 Introduction

9.2 North America

 9.2.1 Key Trends

 9.2.2 Isothermal Nucleic Acid Amplification Technology Market Size & Forecast, By Product, 2022–2035

 9.2.3 Isothermal Nucleic Acid Amplification Technology Market Size & Forecast, By Technology, 2022–2035

 9.2.4 Isothermal Nucleic Acid Amplification Technology Market Size & Forecast, By Application, 2022–2035

 9.2.5 Isothermal Nucleic Acid Amplification Technology Market Size & Forecast, By End User, 2022–2035

 9.2.6 Isothermal Nucleic Acid Amplification Technology Market Size & Forecast, By Country, 2022–2035

  9.2.6.1 USA

  9.2.6.2 Canada

9.3 Europe

 9.3.1 Key Trends

 9.3.2 Isothermal Nucleic Acid Amplification Technology Market Size & Forecast, By Product, 2022–2035

 9.3.3 Isothermal Nucleic Acid Amplification Technology Market Size & Forecast, By Technology, 2022–2035

 9.3.4 Isothermal Nucleic Acid Amplification Technology Market Size & Forecast, By Application, 2022–2035

 9.3.5 Isothermal Nucleic Acid Amplification Technology Market Size & Forecast, By End User, 2022–2035

 9.3.6 Isothermal Nucleic Acid Amplification Technology Market Size & Forecast, By Country, 2022–2035

  9.3.6.1 Germany

  9.3.6.2 UK

  9.3.6.3 France

  9.3.6.4 Italy

  9.3.6.5 Spain

  9.3.6.6 Russia

  9.3.6.7 Poland

  9.3.6.8 Rest of Europe

9.4 Asia-Pacific

 9.4.1 Key Trends

 9.4.2 Isothermal Nucleic Acid Amplification Technology Market Size & Forecast, By Product, 2022–2035

 9.4.3 Isothermal Nucleic Acid Amplification Technology Market Size & Forecast, By Technology, 2022–2035

 9.4.4 Isothermal Nucleic Acid Amplification Technology Market Size & Forecast, By Application, 2022–2035

 9.4.5 Isothermal Nucleic Acid Amplification Technology Market Size & Forecast, By End User, 2022–2035

 9.4.6 Isothermal Nucleic Acid Amplification Technology Market Size & Forecast, By Country, 2022–2035

  9.4.6.1 China

  9.4.6.2 India

  9.4.6.3 Japan

  9.4.6.4 South Korea

  9.4.6.5 Australia

  9.4.6.6 ASEAN Countries

  9.4.6.7 Rest of Asia-Pacific

9.5 Latin America

 9.5.1 Key Trends

 9.5.2 Isothermal Nucleic Acid Amplification Technology Market Size & Forecast, By Product, 2022–2035

 9.5.3 Isothermal Nucleic Acid Amplification Technology Market Size & Forecast, By Technology, 2022–2035

 9.5.4 Isothermal Nucleic Acid Amplification Technology Market Size & Forecast, By Application, 2022–2035

 9.5.5 Isothermal Nucleic Acid Amplification Technology Market Size & Forecast, By End User, 2022–2035

 9.5.6 Isothermal Nucleic Acid Amplification Technology Market Size & Forecast, By Country, 2022–2035

  9.5.6.1 Brazil

  9.5.6.2 Argentina

  9.5.6.3 Mexico

  9.5.6.4 Colombia

  9.5.6.5 Rest of Latin America

9.6 Middle East & Africa

 9.6.1 Key Trends

 9.6.2 Isothermal Nucleic Acid Amplification Technology Market Size & Forecast, By Product, 2022–2035

 9.6.3 Isothermal Nucleic Acid Amplification Technology Market Size & Forecast, By Technology, 2022–2035

 9.6.4 Isothermal Nucleic Acid Amplification Technology Market Size & Forecast, By Application, 2022–2035

 9.6.5 Isothermal Nucleic Acid Amplification Technology Market Size & Forecast, By End User, 2022–2035

 9.6.6 Isothermal Nucleic Acid Amplification Technology Market Size & Forecast, By Country, 2022–2035

  9.6.6.1 UAE

  9.6.6.2 Saudi Arabia

  9.6.6.3 Qatar

  9.6.6.4 Egypt

  9.6.6.5 South Africa

  9.6.6.6 Rest of Middle East & Africa

10. Competitive Landscape

 10.1 Key Players' Positioning

 10.2 Competitive Developments

  10.2.1 Key Strategies Adopted (%), By Key Players, 2025

  10.2.2 Year-Wise Strategies & Development, 2022–2025

  10.2.3 Number of Strategies Adopted by Key Players, 2025

 10.3 Market Share Analysis, 2025

 10.4 Product/Service & Application Benchmarking

  10.4.1 Product/Service Specifications & Features by Key Players

  10.4.2 Product/Service Heatmap by Key Players

  10.4.3 Application Heatmap by Key Players

 10.5 Industry Start-Up & Innovation Landscape

10.6 Key Company Profiles

 10.6.1 Abbott Laboratories (ID NOW)

  10.6.1.1 Company Overview & Snapshot

  10.6.1.2 Product/Service Portfolio

  10.6.1.3 Key Company Financials

  10.6.1.4 SWOT Analysis

 10.6.2 Hologic Inc. (Gen-Probe/Panther Fusion)

 10.6.3 Thermo Fisher Scientific Inc.

 10.6.4 Becton Dickinson and Company

 10.6.5 Qiagen NV

 10.6.6 Grifols SA (Procleix)

 10.6.7 Eiken Chemical Co. Ltd.

 10.6.8 New England Biolabs Inc.

 10.6.9 bioMerieux SA

 10.6.10 Meridian Bioscience Inc.

 10.6.11 Cepheid (Danaher Corporation)

 10.6.12 DiaSorin SpA (Luminex)

 10.6.13 Roche Diagnostics GmbH

 10.6.14 Sherlock Biosciences Inc.

 10.6.15 Atila BioSystems Inc.

 10.6.16 Meso Scale Diagnostics LLC

 10.6.17 Ustar Biotechnologies Ltd.

 10.6.18 OptiGrate Corp.

 10.6.19 TwistDx Ltd. (Abbott)

 10.6.20 Sense Biodetection Ltd.

11. Analyst Recommendations

 11.1 SNS Insider Opportunity Map

 11.2 Industry Low-Hanging Fruit Assessment

 11.3 Market Entry & Growth Strategy

 11.4 Analyst Viewpoint & Suggestions on Market Growth

12. Assumptions

13. Disclaimer

14. Appendix

 14.1 List of Tables

 14.2 List of Figures